DoD's $51M advanced threats research contract awarded to Battelle Memorial Institute shows fair value, but limited competition raises concerns

Contract Overview

Contract Amount: $50,998,777 ($51.0M)

Contractor: Battelle Memorial Institute

Awarding Agency: Department of Defense

Start Date: 2015-06-22

End Date: 2020-06-21

Contract Duration: 1,826 days

Daily Burn Rate: $27.9K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: IGF::OT::IGF INITIAL AWARD HT 15-1087, CROSS COMMODITY ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST,&EVALUATION,&STRATEGIC INITIATIVES JOINT PROGRAM CHEMICAL AND BIOLOGICAL DEFENSE

Place of Performance

Location: COLUMBUS, FRANKLIN County, OHIO, 43201

State: Ohio Government Spending

Plain-Language Summary

Department of Defense obligated $51.0 million to BATTELLE MEMORIAL INSTITUTE for work described as: IGF::OT::IGF INITIAL AWARD HT 15-1087, CROSS COMMODITY ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST,&EVALUATION,&STRATEGIC INITIATIVES JOINT PROGRAM CHEMICAL AND BIOLOGICAL DEFENSE Key points: 1. The contract's value appears reasonable given the specialized R&D nature, aligning with industry benchmarks for similar complex projects. 2. Full and open competition was utilized, but only one bid was received, suggesting potential limitations in the bidding pool or the solicitation process. 3. The cost-plus-fixed-fee (CPFF) contract type carries inherent risk of cost overruns, though oversight can mitigate this. 4. Performance is within the expected timeframe, indicating no immediate red flags regarding project execution. 5. This contract falls within the Defense sector's R&D category, focusing on critical chemical and biological defense capabilities. 6. The lack of small business set-aside indicates no specific provisions were made to encourage small business participation. 7. The contract's duration of 1826 days (5 years) suggests a long-term commitment to the research objectives.

Value Assessment

Rating: good

The contract's total value of approximately $51 million over five years for advanced threat research and development appears to be within a reasonable range for specialized scientific services. Benchmarking against similar Department of Defense R&D contracts for chemical and biological defense indicates that the pricing structure, while not explicitly detailed in terms of per-unit costs, is competitive for the scope of work. The CPFF structure necessitates careful monitoring to ensure cost efficiency, but the overall value proposition seems fair for the critical nature of the research.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, which is generally positive for price discovery. However, the fact that only one bid was received is a significant concern. This could indicate issues with the solicitation's clarity, the perceived complexity of the requirements, or a lack of interested and capable bidders in the market for this specific niche. While the process was open, the limited number of participants restricts the competitive pressure that would typically drive down costs and foster innovation.

Taxpayer Impact: For taxpayers, receiving only one bid under a full and open competition means the government may not have achieved the best possible price. The lack of robust competition limits the opportunity to leverage multiple proposals to identify the most cost-effective solution and potentially secure better terms.

Public Impact

The primary beneficiaries are the Department of Defense and national security, through advancements in chemical and biological defense capabilities. The contract delivers research, development, test, evaluation, and strategic initiatives aimed at countering advanced threats. The geographic impact is primarily within the United States, supporting domestic research institutions and potentially enhancing national security infrastructure. Workforce implications include employment for highly skilled scientists, engineers, and technical personnel within Battelle Memorial Institute and its potential subcontractors.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Limited competition resulting in a single bid raises concerns about potential price inflation and lack of innovative solutions.
The Cost Plus Fixed Fee (CPFF) contract type can incentivize cost overruns if not rigorously managed.
The absence of small business participation may limit opportunities for smaller, specialized firms in this critical R&D area.

Positive Signals

Awarded under full and open competition, theoretically allowing any qualified vendor to bid.
The contract addresses a critical national security need for advanced threat research.
Battelle Memorial Institute is a reputable research institution with a track record in defense-related R&D.

Sector Analysis

The contract falls within the Research and Development (R&D) sector, specifically focusing on physical, engineering, and life sciences, excluding biotechnology. This is a highly specialized area within the broader defense industry. The market for advanced chemical and biological defense research is characterized by high barriers to entry due to the need for specialized expertise, facilities, and security clearances. Comparable spending benchmarks in this niche are difficult to establish precisely due to the unique nature of the research, but the awarded amount aligns with significant R&D investments made by government agencies for critical defense capabilities.

Small Business Impact

This contract did not include a small business set-aside, meaning there were no specific provisions to encourage or mandate the participation of small businesses. Consequently, the primary contractor, Battelle Memorial Institute, will likely handle the majority of the work. While large prime contractors often utilize small business subcontractors, the absence of a set-aside means there's no guarantee of subcontracting opportunities for small businesses in this specific award. This could limit the broader impact on the small business ecosystem within this specialized R&D field.

Oversight & Accountability

Oversight for this contract is managed by the Defense Contract Management Agency (DCMA), which is responsible for ensuring contractor performance, compliance, and financial accountability. The contract's CPFF structure necessitates close monitoring of costs and progress to prevent overruns and ensure value for money. Transparency is generally maintained through contract reporting mechanisms, though specific details of research findings are often classified or proprietary. Inspector General jurisdiction would apply in cases of fraud, waste, or abuse.

Related Government Programs

Department of Defense Research and Development Programs
Chemical and Biological Defense Programs
Advanced Threat Analysis Contracts
National Security Research Initiatives

Risk Flags

Limited competition (single bid) under full and open process.
Cost Plus Fixed Fee contract type carries inherent cost overrun risk.
Lack of specific small business participation provisions.

Frequently Asked Questions

What is this federal contract paying for?

Department of Defense awarded $51.0 million to BATTELLE MEMORIAL INSTITUTE. IGF::OT::IGF INITIAL AWARD HT 15-1087, CROSS COMMODITY ADVANCED THREATS RESEARCH, DEVELOPMENT, TEST,&EVALUATION,&STRATEGIC INITIATIVES JOINT PROGRAM CHEMICAL AND BIOLOGICAL DEFENSE

Who is the contractor on this award?

The obligated recipient is BATTELLE MEMORIAL INSTITUTE.

Which agency awarded this contract?

Awarding agency: Department of Defense (Defense Contract Management Agency).

What is the total obligated amount?

The obligated amount is $51.0 million.

What is the period of performance?

Start: 2015-06-22. End: 2020-06-21.

What is Battelle Memorial Institute's track record with similar Department of Defense R&D contracts?

Battelle Memorial Institute has a substantial track record with the Department of Defense, particularly in research and development, including areas related to chemical and biological defense. They have been a consistent recipient of government contracts for advanced scientific research, testing, and evaluation. Their experience often involves complex, long-term projects requiring specialized expertise and facilities. While specific performance metrics for past contracts are not detailed here, their continued engagement with the DoD suggests a generally positive performance history and a recognized capability in fulfilling critical research requirements. This specific contract, awarded in 2015, builds upon that established relationship and expertise.

How does the $51 million contract value compare to other DoD R&D contracts in chemical and biological defense?

The $51 million contract value for advanced threats research, development, test, evaluation, and strategic initiatives is significant but falls within the expected range for major R&D efforts within the Department of Defense, particularly in specialized fields like chemical and biological defense. Large-scale R&D programs can easily reach tens or hundreds of millions of dollars over their lifecycle, depending on the scope, duration, and complexity. When compared to other contracts for similar advanced research and development services, especially those involving cutting-edge scientific inquiry and testing, this award appears to be a substantial investment but not an outlier. The specific nature of 'advanced threats' suggests a focus on novel and emerging challenges, justifying a considerable budget.

What are the primary risks associated with a Cost Plus Fixed Fee (CPFF) contract for R&D?

The primary risk associated with a Cost Plus Fixed Fee (CPFF) contract, especially for research and development, is the potential for cost overruns. In a CPFF structure, the contractor is reimbursed for allowable costs plus a predetermined fixed fee. While the fee is fixed, the total cost to the government can increase if the contractor's actual costs exceed initial estimates. This can happen due to unforeseen technical challenges, scope creep, or less efficient resource management. For R&D, where the outcomes are inherently uncertain, cost predictability can be challenging. Effective oversight, rigorous cost tracking, and clear performance metrics are crucial to mitigate these risks and ensure the government receives value for its investment.

What does the limited competition (one bid) imply for the effectiveness of this R&D program?

The fact that only one bid was received under a full and open competition for this $51 million R&D contract raises questions about the program's potential effectiveness, primarily due to the lack of competitive pressure. Limited competition can mean that the government did not explore the full range of innovative solutions or cost-saving approaches available in the market. It might suggest that the solicitation was too narrowly defined, the requirements were overly complex, or the market for such specialized R&D is very small. While the single bidder, Battelle Memorial Institute, is a capable entity, the absence of alternatives means the government is reliant on one provider, potentially missing out on better technical approaches or more efficient execution strategies that other bidders might have offered. This could indirectly impact the ultimate effectiveness and value derived from the R&D investment.

How has federal spending in the 'Research and Development in the Physical, Engineering, and Life Sciences' category evolved over time?

Federal spending in the 'Research and Development in the Physical, Engineering, and Life Sciences' category (NAICS code 541712) has historically been substantial, driven by agencies like the Department of Defense, Department of Health and Human Services (NIH), and the National Science Foundation. Spending in this broad category tends to fluctuate based on national priorities, economic conditions, and specific scientific advancements. For instance, periods of heightened national security concerns often lead to increased DoD R&D spending in areas like advanced materials, cybersecurity, and defense technologies. Similarly, public health crises can spur significant investment in biomedical research. While precise year-over-year figures require detailed analysis of federal budget data, this sector consistently represents a significant portion of federal R&D investment, reflecting its critical role in innovation, economic growth, and national security.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENT › OTHER RESEARCH/DEVELOPMENT

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Solicitation ID: FA807512R0002

Offers Received: 1

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 505 KING AVENUE, COLUMBUS, OH, 43201

Business Categories: Category Business, Corporate Entity Tax Exempt, Manufacturer of Goods, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $51,561,227

Exercised Options: $51,561,227

Current Obligation: $50,998,777

Subaward Activity

Number of Subawards: 66

Total Subaward Amount: $66,489,565

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: FA807514D0003

IDV Type: IDC

Timeline